+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Non-opioid Pain Patches Market by Patch Type, Indication, Distribution - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460257
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Non-opioid Pain Patches Market grew from USD 701.29 million in 2023 to USD 790.97 million in 2024. It is expected to continue growing at a CAGR of 12.88%, reaching USD 1.63 billion by 2030.

The market for non-opioid pain patches is defined by transdermal applications designed to deliver pain relief without the use of opioids, utilizing alternative active ingredients such as lidocaine, menthol, or capsaicin. This sector fulfills the necessity of addressing pain management for individuals concerned about the addiction risks and side effects associated with opioid usage. These patches are primarily applied for conditions like localized muscle pain, joint pain, arthritis, and neuropathic pain, offering a convenient and consistent means of pain mitigation. The end-use scope prominently includes hospitals, clinics, and home-care settings, along with a growing segment in sports and fitness for injury recovery. Key influencing growth factors include the increasing prevalence of chronic pain conditions, rising awareness of opioid alternatives, and technological advances in transdermal delivery systems enhancing efficacy and patient comfort. Potential opportunities in this market involve investing in research and development to create patches with enhanced delivery mechanisms, and ingredients targeting specific pain receptors more effectively. Recommendations to seize these opportunities include forming partnerships with medical institutions for clinical research, enhancing consumer education, and leveraging digital marketing strategies to increase market penetration. However, the market faces limitations such as regulatory hurdles associated with medical product approval, potential skin sensitivity reactions, and competition from both traditional pain relief methods and alternative therapies. Challenges also include maintaining cost optimization in manufacturing to ensure affordability. Areas ripe for innovation include the integration of IoT technology for smart patches that monitor and adjust dosages, as well as exploration into plant-based or synthetic compounds that provide longer-lasting pain relief. As the market landscape is highly competitive with rapid technological advancements, businesses should focus on differentiated product development and strategic alliances to maintain a competitive edge.

Understanding Market Dynamics in the Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing Chronic and Acute Pain-Related Disorders
    • Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
    • Benefits Associated with Non-opioid Pain Patches over Conventional Medications
  • Market Restraints
    • Limited Awareness Associated with Non-opioid Pain Patches
  • Market Opportunities
    • Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
    • Rising R&D in Pain Management Treatments
  • Market Challenges
    • Significant Side Effect Coupled with Availability of Alternative Treatments

Exploring Porter’s Five Forces for the Non-opioid Pain Patches Market

Porter’s Five Forces framework further strengthens the insights of the Non-opioid Pain Patches Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Non-opioid Pain Patches Market

External macro-environmental factors deeply influence the performance of the Non-opioid Pain Patches Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-opioid Pain Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Patch Type
    • Capsaicin Patches
    • Diclofenac Patches
    • Ketoprofen Patches
    • Lidocaine Patches
    • Methyl Salicylate Patches
  • Indication
    • Arthritis
    • Back Pain
    • Fibromyalgia
    • Migraines & Headaches
    • Muscle Strain & Sprains
    • Post-Herpetic Neuralgia
  • Distribution
    • Drug Stores
    • Hospitals
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
5.1.2. Restraints
5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
5.1.3. Opportunities
5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
5.1.3.2. Rising R&D in Pain Management Treatments
5.1.4. Challenges
5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Non-opioid Pain Patches Market, by Patch Type
6.1. Introduction
6.2. Capsaicin Patches
6.3. Diclofenac Patches
6.4. Ketoprofen Patches
6.5. Lidocaine Patches
6.6. Methyl Salicylate Patches
7. Non-opioid Pain Patches Market, by Indication
7.1. Introduction
7.2. Arthritis
7.3. Back Pain
7.4. Fibromyalgia
7.5. Migraines & Headaches
7.6. Muscle Strain & Sprains
7.7. Post-Herpetic Neuralgia
8. Non-opioid Pain Patches Market, by Distribution
8.1. Introduction
8.2. Drug Stores
8.3. Hospitals
8.4. Online Pharmacies
9. Americas Non-opioid Pain Patches Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Non-opioid Pain Patches Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Non-opioid Pain Patches Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
FIGURE 2. NON-OPIOID PAIN PATCHES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NON-OPIOID PAIN PATCHES MARKET DYNAMICS
TABLE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 34. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 35. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 52. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 54. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 60. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 61. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 78. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 79. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 89. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 92. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 94. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 95. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 98. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 106. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 107. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 115. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 116. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 118. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 119. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 121. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 122. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 143. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 151. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 152. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Non-opioid Pain Patches Market, which are profiled in this report, include:
  • Bridges Consumer Healthcare, LLC
  • Cardinal Health, Inc.
  • Endo International plc
  • GlaxoSmithKline Plc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • SCILEX Pharmaceuticals Inc.
  • Sorrento Therapeutics, Inc.
  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Veridian Healthcare
  • Virpax Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information